Viruses are extremely tiny—much smaller than bacteria. They invade individual cells and turn them into tiny factories to make more viruses. The pharmaceutical community has developed antibiotic after antibiotic to target an ever-growing group of bacterial pathogens, yet few medicines today work on viral infections. Proline-Rich Polypeptides (PRPs) are one of the key components that virologists all over the world are researching in the battle against the ever growing virus threat. |Read More|